Sovaldi, a $1,000 per pill, has become a common treatment for Hepatitis C but insurers are reluctant to pay the higher costs.
Sovaldi, a $1,000 per pill, has become a common treatment for Hepatitis C but insurers are reluctant to pay the higher costs. Uncredited Gilead Sciences via AP
Sovaldi, a $1,000 per pill, has become a common treatment for Hepatitis C but insurers are reluctant to pay the higher costs. Uncredited Gilead Sciences via AP